AstraZeneca Shares Rise 2% After $2 Billion Summit Therapeutics Investment
Astra Zeneca logo on building ©Adobe Stock Images AstraZeneca (LSE:AZN) shares rose 2.0% on Tuesday after the pharmaceutical…
#EuropeSays #Britain #Europe #EU #AstraZeneca #AstraZenecashares #bispecificantibody #cancertreatments #clinicalcollaboration #equityinvestment #oncologytreatments #pharmaceuticalcompany #SummitTherapeutics
https://www.europesays.com/britain/135376/